Abivax is a France-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer, viral and inflammatory diseases.
$163M
Aug 20, 2023
-
Crescendo is an England-based clinical-stage immuno-oncology company that researches and develops T-cell human body therapeutics for the treatment of cancer.
$32M
Jul 23, 2023
-
Qover is a Belgium-based embedded insurtech platform that offers solutions such as claims management and data analysis for the insurance sector.
$30M
Jul 05, 2023
-
THIS is an England-based food production company that produces and markets plant-based meat products for individuals and retailers.
$17.7M
Mar 08, 2023
-
Sdui is a Germany-based education technology platform that provides digital communication and collaboration solutions for schools and daycare centers.
$27.1M
Jan 31, 2023
-
Frequently Asked Questions about Kreos Capital
What is Kreos Capital investing in?
Kreos Capital has invested in 91 companies including Abivax, Crescendo Biologics and Qover
What company did Kreos Capital invest in?
Kreos Capital invested in a total 91 companies including Abivax, Crescendo Biologics and Qover
What are the top 5 investments by Kreos Capital?
The top companies in which Kreos Capital invested are Abivax, Crescendo Biologics, Qover, THIS and Sdui
